BRAINSWAY LTD/S (NASDAQ:BWAY) – Stock analysts at Oppenheimer issued their Q1 2019 earnings per share estimates for shares of BRAINSWAY LTD/S in a research note issued on Monday, May 13th. Oppenheimer analyst S. Lichtman forecasts that the company will earn ($0.13) per share for the quarter. Oppenheimer has a “Outperform” rating and a $17.00 price target on the stock. Oppenheimer also issued estimates for BRAINSWAY LTD/S’s Q2 2019 earnings at ($0.12) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.14) EPS, FY2019 earnings at ($0.52) EPS, FY2020 earnings at ($0.40) EPS and FY2021 earnings at ($0.18) EPS.

A number of other research firms also recently issued reports on BWAY. Raymond James started coverage on shares of BRAINSWAY LTD/S in a research report on Monday. They set an “outperform” rating and a $14.00 target price for the company. LADENBURG THALM/SH SH started coverage on shares of BRAINSWAY LTD/S in a research report on Monday. They set a “buy” rating and a $19.00 target price for the company. CIBC started coverage on shares of BRAINSWAY LTD/S in a research report on Monday. They set an “outperform” rating for the company. Finally, Cantor Fitzgerald started coverage on shares of BRAINSWAY LTD/S in a research report on Monday. They set an “overweight” rating and a $17.00 target price for the company. Five analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus target price of $16.75.

NASDAQ BWAY opened at $10.71 on Thursday. BRAINSWAY LTD/S has a 1 year low of $10.30 and a 1 year high of $12.39.

BRAINSWAY LTD/S Company Profile

Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.

Recommended Story: What is net income?

Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.